Article

Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19

2022-06-26

Abstract excerpt

COVID-19 has affected more than half a billion people worldwide, with more than 6.3 million deaths, but the pathophysiological mechanisms involved in lethal cases and the host determinants that determine the different clinical outcomes are still unclear. In this study, we assessed lung autopsies of 47 COVID-19 patients and examined the inflammatory profiles, viral loads, and inflammasome activation. Additionally,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 00e92800-6bab-5277-b38b-a580d17ed1bc
DOI: 10.1101/2022.06.24.22276878

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19DOI 10.1101/2022.06.24.22276878Read

COVID-19: role of the NLRP3 inflammasomeSemantic proximity Read

SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeuticsSemantic proximity Read

Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in PatientsSemantic proximity Read

Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolutionSemantic proximity Read

Two distinct immunopathological profiles in autopsy lungs of COVID-19Semantic proximity Read

Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19Semantic proximity Read

Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.Semantic proximity Read

Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortalitySemantic proximity Read

Single-cell RNA sequencing reveals characteristics of myeloid cells in pulmonary post-acute sequelae of SARS-CoV-2Semantic proximity Read

Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomesSemantic proximity Read

Deciphering the state of immune silence in fatal COVID-19 patientsSemantic proximity Read

Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19Semantic proximity Read